Pilot study of Resveratrol in patients with Glaucoma

Phase 1

Not yet recruiting

• Conditions: Glaucoma; Eye - Diseases / disorders of the eye

• Registration Number: ACTRN12612000258853
• Lead Sponsor: Centre for Eye Research Australia

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2012-03-01
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Not yet recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Patients with ocular hypertension, mild to moderate glaucoma

Exclusion Criteria

Advanced glaucoma
Pregnancy
Severe renal or hepatic impairment
Documented allergy to Resveratrol

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in electroretinogram (ERG) recordings[2 weeks, 4 weeks and 8 weeks]

Secondary Outcome Measures

Name	Time	Method
il[N/A]